Barclays PLC Grows Stock Holdings in Sotera Health (NASDAQ:SHC)

Barclays PLC increased its position in Sotera Health (NASDAQ:SHC - Free Report) by 169.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 473,597 shares of the company's stock after acquiring an additional 298,085 shares during the period. Barclays PLC owned about 0.17% of Sotera Health worth $7,909,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. True Wealth Design LLC purchased a new stake in shares of Sotera Health during the 3rd quarter valued at about $32,000. CWM LLC boosted its holdings in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company's stock worth $25,000 after purchasing an additional 993 shares during the last quarter. GAMMA Investing LLC grew its position in Sotera Health by 125.0% in the 3rd quarter. GAMMA Investing LLC now owns 2,988 shares of the company's stock worth $50,000 after purchasing an additional 1,660 shares during the period. Capital Performance Advisors LLP purchased a new stake in Sotera Health during the 3rd quarter valued at $91,000. Finally, Point72 DIFC Ltd lifted its holdings in shares of Sotera Health by 556.6% during the 2nd quarter. Point72 DIFC Ltd now owns 6,540 shares of the company's stock valued at $78,000 after buying an additional 5,544 shares during the period. 91.03% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on SHC. Citigroup upped their target price on shares of Sotera Health from $18.00 to $20.00 and gave the company a "buy" rating in a report on Wednesday, November 6th. Royal Bank of Canada restated an "outperform" rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Thursday, November 21st. Finally, The Goldman Sachs Group started coverage on Sotera Health in a research report on Friday, December 6th. They set a "neutral" rating and a $14.00 target price on the stock. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $16.08.

Sotera Health Trading Up 0.9 %

Shares of Sotera Health stock traded up $0.12 on Wednesday, reaching $13.20. The company had a trading volume of 1,674,765 shares, compared to its average volume of 1,336,528. The firm has a market cap of $3.74 billion, a price-to-earnings ratio of 52.80 and a beta of 1.96. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The firm's 50-day moving average price is $14.51 and its two-hundred day moving average price is $14.21. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. During the same quarter in the previous year, the company posted $0.18 earnings per share. The business's revenue for the quarter was up 8.5% on a year-over-year basis. As a group, research analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.